Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
Clinical and Experimental Medicine|November 7, 2023
Pan-PI3K inhibition with copanlisib overcomes Treg- and M2-TAM-mediated immune suppression and promotes anti-tumor immune responsesSimon Heller, Sarah Glaeske, Katja Gluske, et al.BMC Cancer|June 3, 2010
CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patientsDimo Dietrich, Manuel Krispin, Jörn Dietrich, et al.Annals of the Rheumatic Diseases|August 2, 2018
Intrarenal activation of adaptive immune effectors is associated with tubular damage and impaired renal function in lupus nephritisCristina Pamfil, Zuzanna Makowska, Aurélie De Groof, et al.Cancers|January 18, 2020
Characterization of the Menin-MLL Interaction as Therapeutic Cancer TargetKrzysztof Brzezinka, Ekaterina Nevedomskaya, Ralf Lesche, et al.Iscience|June 18, 2021
RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescenceJoseph L Regan, Dirk Schumacher, Stephanie Staudte, et al.Arthritis & Rheumatology (Hoboken, N.J.)|January 17, 2021
Expression Quantitative Trait Locus Analysis in Systemic Sclerosis Identifies New Candidate Genes Associated With Multiple Aspects of Disease PathologyMartin Kerick, David González-Serna, Elena Carnero-Montoro, et al.Molecular Cancer Therapeutics|August 18, 2018
Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of ResistanceMaria Quanz, Eckhard Bender, Charlotte Kopitz, et al.Iscience|June 20, 2022
Identification of a neural development gene expression signature in colon cancer stem cells reveals a role for EGR2 in tumorigenesisJoseph L Regan, Dirk Schumacher, Stephanie Staudte, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapyOliver Hartmann, Frédérique Spyratos, Nadia Harbeck, et al.Frontiers in Immunology|May 29, 2026
Assessing the translational relevance of specific molecular pathways in spontaneous lupus mouse modelsMaría Rivas-Torrubia, María Morell, Zuzanna Makowska, et al.Pageof 6